{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "exchange": "KOE", "shortName": "ABL Bio", "longName": "ABL Bio Inc.", "exchangeTimezoneName": "Asia/Seoul", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "market": "kr_market", "esgPopulated": false, "regularMarketChangePercent": -0.22988506, "regularMarketPrice": 21700.0, "marketState": "PREPRE", "fiftyTwoWeekHighChangePercent": -0.21090908, "fiftyTwoWeekLow": 17050.0, "fiftyTwoWeekHigh": 27500.0, "earningsTimestamp": 1676026740, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684497600, "sharesOutstanding": 45303400, "fiftyDayAverage": 22214.0, "fiftyDayAverageChange": -514.0, "fiftyDayAverageChangePercent": -0.02313856, "twoHundredDayAverage": 21843.65, "twoHundredDayAverageChange": -143.65039, "twoHundredDayAverageChangePercent": -0.0065762997, "marketCap": 983083778048, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": -50.0, "regularMarketTime": 1683873010, "regularMarketDayHigh": 21850.0, "regularMarketDayRange": "21350.0 - 21850.0", "regularMarketDayLow": 21350.0, "regularMarketVolume": 247443, "regularMarketPreviousClose": 21750.0, "bid": 21650.0, "ask": 21700.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KOSDAQ", "financialCurrency": "KRW", "regularMarketOpen": 21750.0, "averageDailyVolume3Month": 609655, "averageDailyVolume10Day": 347151, "fiftyTwoWeekLowChange": 4650.0, "fiftyTwoWeekLowChangePercent": 0.27272728, "fiftyTwoWeekRange": "17050.0 - 27500.0", "fiftyTwoWeekHighChange": -5800.0, "firstTradeDateMilliseconds": 1545177600000, "symbol": "298380.KQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "16 Daewangpangyo-Ro 712 Beon-Gil", "address2": "2nd Floor Bundang-Gu", "city": "Seongnam-si", "zip": "13488", "country": "South Korea", "phone": "82 31 8018 9800", "website": "https://www.ablbio.com", "industry": "", "sector": "", "longBusinessSummary": "ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam, South Korea.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sang Hoon  Lee Ph.D.", "title": "Founder, Pres & CEO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jaecheon  Lee M.B.A., MBA", "title": "Exec. VP, MD & CFO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jung Dae  Kim M.B.A.", "title": "Exec. VP & COO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. You  Weon-Kyoo PH.D.", "title": "Exec. VP, Chief Scientific Officer & Head of R&D", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jae Ho  Jung Ph.D.", "title": "Exec. VP & Chief of Discovery", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jong Hwa  Won Ph.D.", "title": "Exec. VP,  Chief Translational Research Officer & Head of Early Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Eunkyung  Kim M.D., Ph.D.", "title": "Head of Medical & Clinical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}